Annual report
4452.TEDINET S100XT6G
Period2025-01-01 → 2025-12-31
Filed2026-03-25
StandardIFRS
ConsolidatedYes
Data checks19 of 19 passed
Key figures · 153
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥1.69T | 2025-01-01 → 2025-12-31 | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥1.63T | 2024-01-01 → 2024-12-31 | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥1.53T | 2023-01-01 → 2023-12-31v | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥1.55T | 2022-01-01 → 2022-12-31v | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥1.42T | 2021-01-01 → 2021-12-31d | Cons. | Revenue IFRS (5-year summary) |
| Operating income | ¥164.1bn | 2025-01-01 → 2025-12-31 | Cons. | Operating profit loss IFRS |
| Operating income | ¥146.6bn | 2024-01-01 → 2024-12-31 | Cons. | Operating profit loss IFRS |
| Profit before tax | ¥169.8bn | 2025-01-01 → 2025-12-31 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥151.0bn | 2024-01-01 → 2024-12-31 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥63.8bn | 2023-01-01 → 2023-12-31v | Cons. | Profit loss before tax IFRS (5-year summary) |
| Profit before tax | ¥115.8bn | 2022-01-01 → 2022-12-31v | Cons. | Profit loss before tax IFRS (5-year summary) |
| Profit before tax | ¥150.0bn | 2021-01-01 → 2021-12-31d | Cons. | Profit loss before tax IFRS (5-year summary) |
| Net income (owners) | ¥120.1bn | 2025-01-01 → 2025-12-31 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥107.8bn | 2024-01-01 → 2024-12-31 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥43.9bn | 2023-01-01 → 2023-12-31v | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income (owners) | ¥86.0bn | 2022-01-01 → 2022-12-31v | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income (owners) | ¥109.6bn | 2021-01-01 → 2021-12-31d | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income | ¥120.6bn | 2025-01-01 → 2025-12-31 | Cons. | Profit loss IFRS |
| Net income | ¥110.4bn | 2024-01-01 → 2024-12-31 | Cons. | Profit loss IFRS |
| Total assets | ¥1.88T | at 2025-12-31 | Cons. | Assets IFRS |
| Total assets | ¥1.87T | at 2024-12-31 | Cons. | Assets IFRS |
| Total assets | ¥1.77T | at 2023-12-31v | Cons. | Total assets IFRS (5-year summary) |
| Total assets | ¥1.73T | at 2022-12-31v | Cons. | Total assets IFRS (5-year summary) |
| Total assets | ¥1.70T | at 2021-12-31d | Cons. | Total assets IFRS (5-year summary) |
| Total liabilities | ¥780.4bn | at 2025-12-31 | Cons. | Liabilities IFRS |
| Total liabilities | ¥768.4bn | at 2024-12-31 | Cons. | Liabilities IFRS |
| Net assets / equity | ¥1.09T | at 2025-12-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥1.10T | at 2024-12-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥1.01T | at 2023-12-31v | Cons. | Equity IFRS |
| Equity (owners) | ¥1.06T | at 2025-12-31 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥1.07T | at 2024-12-31 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥983.7bn | at 2023-12-31v | Cons. | Equity attributable to owners of parent IFRS (5-year summary) |
| Equity (owners) | ¥972.1bn | at 2022-12-31v | Cons. | Equity attributable to owners of parent IFRS (5-year summary) |
| Equity (owners) | ¥965.1bn | at 2021-12-31d | Cons. | Equity attributable to owners of parent IFRS (5-year summary) |
| Cash & equivalents | ¥323.3bn | at 2025-12-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥357.7bn | at 2024-12-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥291.7bn | at 2023-12-31v | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥268.2bn | at 2022-12-31v | Cons. | Cash and cash equivalents IFRS (5-year summary) |
| Cash & equivalents | ¥336.1bn | at 2021-12-31d | Cons. | Cash and cash equivalents IFRS (5-year summary) |
| Operating cash flow | ¥199.7bn | 2025-01-01 → 2025-12-31 | Cons. | Net cash provided by used in operating activities IFRS |
| Operating cash flow | ¥201.6bn | 2024-01-01 → 2024-12-31 | Cons. | Net cash provided by used in operating activities IFRS |
| Operating cash flow | ¥202.5bn | 2023-01-01 → 2023-12-31v | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Operating cash flow | ¥130.9bn | 2022-01-01 → 2022-12-31v | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Operating cash flow | ¥175.5bn | 2021-01-01 → 2021-12-31d | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Investing cash flow | −¥69.8bn | 2025-01-01 → 2025-12-31 | Cons. | Net cash provided by used in investing activities IFRS |
| Investing cash flow | −¥45.9bn | 2024-01-01 → 2024-12-31 | Cons. | Net cash provided by used in investing activities IFRS |
| Investing cash flow | −¥109.3bn | 2023-01-01 → 2023-12-31v | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Investing cash flow | −¥74.9bn | 2022-01-01 → 2022-12-31v | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Investing cash flow | −¥67.2bn | 2021-01-01 → 2021-12-31d | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Financing cash flow | −¥175.1bn | 2025-01-01 → 2025-12-31 | Cons. | Net cash provided by used in financing activities IFRS |
| Financing cash flow | −¥104.6bn | 2024-01-01 → 2024-12-31 | Cons. | Net cash provided by used in financing activities IFRS |
| Financing cash flow | −¥80.0bn | 2023-01-01 → 2023-12-31v | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| Financing cash flow | −¥139.3bn | 2022-01-01 → 2022-12-31v | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| Financing cash flow | −¥141.6bn | 2021-01-01 → 2021-12-31d | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| EPS (basic) | ¥260.3 | 2025-01-01 → 2025-12-31 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥231.94 | 2024-01-01 → 2024-12-31 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥94.37 | 2023-01-01 → 2023-12-31v | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (basic) | ¥183.28 | 2022-01-01 → 2022-12-31v | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (basic) | ¥230.59 | 2021-01-01 → 2021-12-31d | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥94.37 | 2023-01-01 → 2023-12-31v | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥183.27 | 2022-01-01 → 2022-12-31v | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥230.57 | 2021-01-01 → 2021-12-31d | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| Net assets per share | ¥2,352.49 | at 2025-12-31 | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Net assets per share | ¥2,296.69 | at 2024-12-31 | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Net assets per share | ¥2,116.01 | at 2023-12-31v | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Net assets per share | ¥2,091.2 | at 2022-12-31v | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Net assets per share | ¥2,036.66 | at 2021-12-31d | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Equity ratio | 56.7% | at 2025-12-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 57.1% | at 2024-12-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 55.6% | at 2023-12-31v | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 56.3% | at 2022-12-31v | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 56.6% | at 2021-12-31d | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| ROE | 11.3% | 2025-01-01 → 2025-12-31 | Cons. | Rate of return on equity IFRS (5-year summary) |
| ROE | 10.5% | 2024-01-01 → 2024-12-31 | Cons. | Rate of return on equity IFRS (5-year summary) |
| ROE | 4.5% | 2023-01-01 → 2023-12-31v | Cons. | Rate of return on equity IFRS (5-year summary) |
| ROE | 8.9% | 2022-01-01 → 2022-12-31v | Cons. | Rate of return on equity IFRS (5-year summary) |
| ROE | 11.6% | 2021-01-01 → 2021-12-31d | Cons. | Rate of return on equity IFRS (5-year summary) |
| Employees | 31,514 | at 2025-12-31 | Cons. | Number of employees |
| Employees | 32,566 | at 2024-12-31 | Cons. | Number of employees |
| Employees | 34,257 | at 2023-12-31v | Cons. | Number of employees |
| Employees | 35,411 | at 2022-12-31v | Cons. | Number of employees |
| Employees | 33,507 | at 2021-12-31d | Cons. | Number of employees |
| Revenue | ¥934.8bn | 2025-01-01 → 2025-12-31 | Standalone | Net sales |
| Revenue | ¥898.1bn | 2024-01-01 → 2024-12-31 | Standalone | Net sales |
| Revenue | ¥868.1bn | 2023-01-01 → 2023-12-31v | Standalone | Net sales (5-year summary) |
| Revenue | ¥871.7bn | 2022-01-01 → 2022-12-31v | Standalone | Net sales (5-year summary) |
| Revenue | ¥872.9bn | 2021-01-01 → 2021-12-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥93.7bn | 2025-01-01 → 2025-12-31 | Standalone | Operating income |
| Operating income | ¥62.9bn | 2024-01-01 → 2024-12-31 | Standalone | Operating income |
| Ordinary income | ¥132.0bn | 2025-01-01 → 2025-12-31 | Standalone | Ordinary income |
| Ordinary income | ¥104.4bn | 2024-01-01 → 2024-12-31 | Standalone | Ordinary income |
| Ordinary income | ¥47.6bn | 2023-01-01 → 2023-12-31v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥99.2bn | 2022-01-01 → 2022-12-31v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥135.6bn | 2021-01-01 → 2021-12-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥129.4bn | 2025-01-01 → 2025-12-31 | Standalone | Income before income taxes |
| Profit before tax | ¥110.1bn | 2024-01-01 → 2024-12-31 | Standalone | Income before income taxes |
| Net income | ¥103.0bn | 2025-01-01 → 2025-12-31 | Standalone | Profit loss |
| Net income | ¥91.7bn | 2024-01-01 → 2024-12-31 | Standalone | Profit loss |
| Net income | ¥28.0bn | 2023-01-01 → 2023-12-31v | Standalone | Net income loss (5-year summary) |
| Net income | ¥79.1bn | 2022-01-01 → 2022-12-31v | Standalone | Net income loss (5-year summary) |
| Net income | ¥101.6bn | 2021-01-01 → 2021-12-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥1.29T | at 2025-12-31 | Standalone | Assets |
| Total assets | ¥1.29T | at 2024-12-31 | Standalone | Assets |
| Total assets | ¥1.24T | at 2023-12-31v | Standalone | Total assets (5-year summary) |
| Total assets | ¥1.21T | at 2022-12-31v | Standalone | Total assets (5-year summary) |
| Total assets | ¥1.26T | at 2021-12-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥607.1bn | at 2025-12-31 | Standalone | Liabilities |
| Total liabilities | ¥565.0bn | at 2024-12-31 | Standalone | Liabilities |
| Net assets / equity | ¥678.9bn | at 2025-12-31 | Standalone | Net assets |
| Net assets / equity | ¥726.3bn | at 2024-12-31 | Standalone | Net assets |
| Net assets / equity | ¥707.0bn | at 2023-12-31v | Standalone | Net assets |
| Net assets / equity | ¥747.9bn | at 2022-12-31v | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥787.6bn | at 2021-12-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥101.7bn | at 2025-12-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥140.5bn | at 2024-12-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥222.99 | 2025-01-01 → 2025-12-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥197.22 | 2024-01-01 → 2024-12-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥60.17 | 2023-01-01 → 2023-12-31v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥168.37 | 2022-01-01 → 2022-12-31v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥213.52 | 2021-01-01 → 2021-12-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥60.17 | 2023-01-01 → 2023-12-31v | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥168.36 | 2022-01-01 → 2022-12-31v | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥213.5 | 2021-01-01 → 2021-12-31d | Standalone | Diluted earnings per share (5-year summary) |
| Dividend per share | ¥154 | 2025-01-01 → 2025-12-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥152 | 2024-01-01 → 2024-12-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥150 | 2023-01-01 → 2023-12-31v | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥148 | 2022-01-01 → 2022-12-31v | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥144 | 2021-01-01 → 2021-12-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥1,498.98 | at 2025-12-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,561.67 | at 2024-12-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,518.89 | at 2023-12-31v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,606.78 | at 2022-12-31v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,659.61 | at 2021-12-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 52.8% | at 2025-12-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 56.2% | at 2024-12-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 57.0% | at 2023-12-31v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 61.8% | at 2022-12-31v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 62.3% | at 2021-12-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 14.7% | 2025-01-01 → 2025-12-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 12.8% | 2024-01-01 → 2024-12-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 3.8% | 2023-01-01 → 2023-12-31v | Standalone | Rate of return on equity (5-year summary) |
| ROE | 10.3% | 2022-01-01 → 2022-12-31v | Standalone | Rate of return on equity (5-year summary) |
| ROE | 12.8% | 2021-01-01 → 2021-12-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 453,600,000 | at 2025-12-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 465,900,000 | at 2024-12-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 465,900,000 | at 2023-12-31v | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 465,900,000 | at 2022-12-31v | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 475,000,000 | at 2021-12-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 7,761 | at 2025-12-31 | Standalone | Number of employees |
| Employees | 7,861 | at 2024-12-31 | Standalone | Number of employees |
| Employees | 8,199 | at 2023-12-31v | Standalone | Number of employees |
| Employees | 8,403 | at 2022-12-31v | Standalone | Number of employees |
| Employees | 8,508 | at 2021-12-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 44
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | capex | 2025-01-01 → 2025-12-31 | ¥6.5bn |
| Reconciling Itemsreconciling | segment profit | 2025-01-01 → 2025-12-31 | ¥807m |
| Business Connected Businessreportable segment | capex | 2025-01-01 → 2025-12-31 | ¥1.3bn |
| Business Connected Businessreportable segment | employees | at 2025-12-31 | 841 pure |
| Business Connected Businessreportable segment | segment profit | 2025-01-01 → 2025-12-31 | ¥2.3bn |
| Chemical Businessreportable segment | capex | 2025-01-01 → 2025-12-31 | ¥30.5bn |
| Chemical Businessreportable segment | employees | at 2025-12-31 | 4068 pure |
| Chemical Businessreportable segment | segment profit | 2025-01-01 → 2025-12-31 | ¥30.2bn |
| Cosmetics Businessreportable segment | capex | 2025-01-01 → 2025-12-31 | ¥13.4bn |
| Cosmetics Businessreportable segment | employees | at 2025-12-31 | 9331 pure |
| Cosmetics Businessreportable segment | segment profit | 2025-01-01 → 2025-12-31 | ¥10.4bn |
| Global Consumer Care Businessreportable segment | capex | 2025-01-01 → 2025-12-31 | ¥64.2bn |
| Global Consumer Care Businessreportable segment | employees | at 2025-12-31 | 26192 pure |
| Global Consumer Care Businessreportable segment | segment profit | 2025-01-01 → 2025-12-31 | ¥133.1bn |
| Health Beauty Care Businessreportable segment | capex | 2025-01-01 → 2025-12-31 | ¥17.2bn |
| Health Beauty Care Businessreportable segment | employees | at 2025-12-31 | 7521 pure |
| Health Beauty Care Businessreportable segment | segment profit | 2025-01-01 → 2025-12-31 | ¥39.1bn |
| Hygiene Living Care Businessreportable segment | capex | 2025-01-01 → 2025-12-31 | ¥32.3bn |
| Hygiene Living Care Businessreportable segment | employees | at 2025-12-31 | 8499 pure |
| Hygiene Living Care Businessreportable segment | segment profit | 2025-01-01 → 2025-12-31 | ¥81.3bn |
| —segment total | capex | 2025-01-01 → 2025-12-31 | ¥94.7bn |
| —segment total | segment profit | 2025-01-01 → 2025-12-31 | ¥163.3bn |
| Reconciling Itemsreconciling | capex | 2024-01-01 → 2024-12-31 | ¥1.1bn |
| Reconciling Itemsreconciling | segment profit | 2024-01-01 → 2024-12-31 | −¥823m |
| Business Connected Businessreportable segment | capex | 2024-01-01 → 2024-12-31 | ¥1.7bn |
| Business Connected Businessreportable segment | segment profit | 2024-01-01 → 2024-12-31 | ¥5.2bn |
| Chemical Businessreportable segment | capex | 2024-01-01 → 2024-12-31 | ¥28.6bn |
| Chemical Businessreportable segment | segment profit | 2024-01-01 → 2024-12-31 | ¥35.7bn |
| Cosmetics Businessreportable segment | capex | 2024-01-01 → 2024-12-31 | ¥15.1bn |
| Cosmetics Businessreportable segment | segment profit | 2024-01-01 → 2024-12-31 | −¥3.7bn |
| Global Consumer Care Businessreportable segment | capex | 2024-01-01 → 2024-12-31 | ¥63.8bn |
| Global Consumer Care Businessreportable segment | segment profit | 2024-01-01 → 2024-12-31 | ¥111.7bn |
| Health Beauty Care Businessreportable segment | capex | 2024-01-01 → 2024-12-31 | ¥18.6bn |
| Health Beauty Care Businessreportable segment | segment profit | 2024-01-01 → 2024-12-31 | ¥34.4bn |
| Hygiene Living Care Businessreportable segment | capex | 2024-01-01 → 2024-12-31 | ¥28.4bn |
| Hygiene Living Care Businessreportable segment | segment profit | 2024-01-01 → 2024-12-31 | ¥75.8bn |
| —segment total | capex | 2024-01-01 → 2024-12-31 | ¥92.5bn |
| —segment total | segment profit | 2024-01-01 → 2024-12-31 | ¥147.5bn |
| Business Connected Businessreportable segment | employees | at 2025-12-31 | 163 pure |
| Chemical Businessreportable segment | employees | at 2025-12-31 | 1177 pure |
| Cosmetics Businessreportable segment | employees | at 2025-12-31 | 1256 pure |
| Global Consumer Care Businessreportable segment | employees | at 2025-12-31 | 5398 pure |
| Health Beauty Care Businessreportable segment | employees | at 2025-12-31 | 1793 pure |
| Hygiene Living Care Businessreportable segment | employees | at 2025-12-31 | 2186 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 2,198
| Item | Context | Value | Unit |
|---|---|---|---|
| Operating profit loss IFRS | CurrentYearDuration_jpcrp030000-asr_E00883-000BusinessConnectedBusinessReportableSegmentMember | 2254000000 | JPY |
| Operating profit loss IFRS | CurrentYearDuration_jpcrp030000-asr_E00883-000GlobalConsumerCareBusinessReportableSegmentMember | 133074000000 | JPY |
| Operating profit loss IFRS | CurrentYearDuration_jpcrp030000-asr_E00883-000ChemicalBusinessReportableSegmentMember | 30188000000 | JPY |
| Operating profit loss IFRS | CurrentYearDuration_ReportableSegmentsMember | 163262000000 | JPY |
| Operating profit loss IFRS | CurrentYearDuration_ReconcilingItemsMember | 807000000 | JPY |
| Operating profit loss IFRS | CurrentYearDuration | 164069000000 | JPY |
| Finance income IFRS | CurrentYearDuration | 6198000000 | JPY |
| Finance costs IFRS | CurrentYearDuration | 3827000000 | JPY |
| Share of profit loss of investments accounted for using equity method IFRS | CurrentYearDuration | 3406000000 | JPY |
| Profit loss before tax IFRS | CurrentYearDuration | 169846000000 | JPY |
| Depreciation and amortization operating expenses IFRS | CurrentYearDuration_jpcrp030000-asr_E00883-000HygieneLivingCareBusinessReportableSegmentMember | 30657000000 | JPY |
| Depreciation and amortization operating expenses IFRS | CurrentYearDuration_jpcrp030000-asr_E00883-000HealthBeautyCareBusinessReportableSegmentMember | 19789000000 | JPY |
| Depreciation and amortization operating expenses IFRS | CurrentYearDuration_jpcrp030000-asr_E00883-000CosmeticsBusinessReportableSegmentMember | 11546000000 | JPY |
| Depreciation and amortization operating expenses IFRS | CurrentYearDuration_jpcrp030000-asr_E00883-000BusinessConnectedBusinessReportableSegmentMember | 1397000000 | JPY |
| Depreciation and amortization operating expenses IFRS | CurrentYearDuration_jpcrp030000-asr_E00883-000GlobalConsumerCareBusinessReportableSegmentMember | 63389000000 | JPY |
| Depreciation and amortization operating expenses IFRS | CurrentYearDuration_jpcrp030000-asr_E00883-000ChemicalBusinessReportableSegmentMember | 20477000000 | JPY |
| Depreciation and amortization operating expenses IFRS | CurrentYearDuration_ReportableSegmentsMember | 83866000000 | JPY |
| Depreciation and amortization operating expenses IFRS | CurrentYearDuration_ReconcilingItemsMember | 1975000000 | JPY |
| Depreciation and amortization operating expenses IFRS | CurrentYearDuration | 85841000000 | JPY |
| Impairment losses pl IFRS | CurrentYearDuration_jpcrp030000-asr_E00883-000HygieneLivingCareBusinessReportableSegmentMember | 126000000 | JPY |
| Impairment losses pl IFRS | CurrentYearDuration_jpcrp030000-asr_E00883-000HealthBeautyCareBusinessReportableSegmentMember | 12000000 | JPY |
| Impairment losses pl IFRS | CurrentYearDuration_jpcrp030000-asr_E00883-000CosmeticsBusinessReportableSegmentMember | 20000000 | JPY |
| Impairment losses pl IFRS | CurrentYearDuration_jpcrp030000-asr_E00883-000BusinessConnectedBusinessReportableSegmentMember | 0 | JPY |
| Impairment losses pl IFRS | CurrentYearDuration_jpcrp030000-asr_E00883-000GlobalConsumerCareBusinessReportableSegmentMember | 158000000 | JPY |
| Impairment losses pl IFRS | CurrentYearDuration_jpcrp030000-asr_E00883-000ChemicalBusinessReportableSegmentMember | 143000000 | JPY |
| Impairment losses pl IFRS | CurrentYearDuration_ReportableSegmentsMember | 301000000 | JPY |
| Impairment losses pl IFRS | CurrentYearDuration_ReconcilingItemsMember | － | JPY |
| Impairment losses pl IFRS | CurrentYearDuration | 301000000 | JPY |
| Capital expenditures IFRS | CurrentYearDuration_jpcrp030000-asr_E00883-000HygieneLivingCareBusinessReportableSegmentMember | 32276000000 | JPY |
| Capital expenditures IFRS | CurrentYearDuration_jpcrp030000-asr_E00883-000HealthBeautyCareBusinessReportableSegmentMember | 17171000000 | JPY |
| Capital expenditures IFRS | CurrentYearDuration_jpcrp030000-asr_E00883-000CosmeticsBusinessReportableSegmentMember | 13409000000 | JPY |
| Capital expenditures IFRS | CurrentYearDuration_jpcrp030000-asr_E00883-000BusinessConnectedBusinessReportableSegmentMember | 1321000000 | JPY |
| Capital expenditures IFRS | CurrentYearDuration_jpcrp030000-asr_E00883-000GlobalConsumerCareBusinessReportableSegmentMember | 64177000000 | JPY |
| Capital expenditures IFRS | CurrentYearDuration_jpcrp030000-asr_E00883-000ChemicalBusinessReportableSegmentMember | 30496000000 | JPY |
| Capital expenditures IFRS | CurrentYearDuration_ReportableSegmentsMember | 94673000000 | JPY |
| Capital expenditures IFRS | CurrentYearDuration_ReconcilingItemsMember | 6463000000 | JPY |
| Capital expenditures IFRS | CurrentYearDuration | 101136000000 | JPY |
| Merchandise and finished goods ca IFRS | Prior1YearInstant | 209163000000 | JPY |
| Merchandise and finished goods ca IFRS | CurrentYearInstant | 220991000000 | JPY |
| Work in process ca IFRS | Prior1YearInstant | 15193000000 | JPY |
| Work in process ca IFRS | CurrentYearInstant | 18188000000 | JPY |
| Raw materials and supplies ca IFRS | Prior1YearInstant | 50272000000 | JPY |
| Raw materials and supplies ca IFRS | CurrentYearInstant | 53187000000 | JPY |
| Inventories ca IFRS | Prior1YearInstant | 274628000000 | JPY |
| Inventories ca IFRS | CurrentYearInstant | 292366000000 | JPY |
| Buildings and structures acquisition cost IFRS | Prior1YearInstant | 508510000000 | JPY |
| Machinery and vehicles acquisition cost IFRS | Prior1YearInstant | 873222000000 | JPY |
| Tools furniture and fixtures acquisition cost IFRS | Prior1YearInstant | 133529000000 | JPY |
| Land acquisition cost IFRS | Prior1YearInstant | 90080000000 | JPY |
| Construction in progress acquisition cost IFRS | Prior1YearInstant | 46557000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 19 of 19 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |